Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Integrated Solution for Diabetes Testing Is Efficient

By HospiMedica staff writers
Posted on 28 Aug 2007
Clinical laboratories will be provided with an integrated system for diabetes testing that automates sample processing, eliminates sample splitting, and improves operating efficiency while reducing costs and errors.

Sysmex America, Inc. More...
(Mundelein, IL, USA) and Bio-Rad Laboratories, Inc. (Hercules, CA, USA) have entered into a non-exclusive, multi-year distribution agreement to jointly market their complementary products with the aim of improving the efficiency and quality of diabetes testing. Sysmex will add Bio-Rad's diabetes testing method to the Sysmex HST-N automation line. Bio-Rad will supply their Variant II turbo link. Sysmex and Bio-Rad will work together to provide seamless service, training, installation, and customer support services.

Bio-Rad's hemoglobin A1c (A1C) blood test measures the amount of glucose attached to the hemoglobin in the red blood cell. This provides an estimate of how well blood glucose levels have been controlled during the previous three to four months. Bio-Rad's test is the industry's gold standard technology for determining whether a patient's diabetes is under control.

We are delighted to continue our long-standing history with Bio-Rad Laboratories, said John Kershaw, president, Sysmex America. The Bio-Rad Variant II turbo link is a perfect complement to the Sysmex HST-N hematology automation line. With the addition of A1c to our automation line, we can truly manage all the testing of the lavender top hematology sample tubes in the laboratory. Sysmex's lavender top management system provides hematology laboratories with the ability to conduct analysis of 90% of tests compatible with EDTA samples, such as complete blood count (CBC), Clostridium difficile, erythrocyte sedimentation rate (ESR), and A1c.

We are pleased to work with Sysmex in offering this integrated testing solution to clinical laboratories as it will enable them to provide superior diabetes testing services to doctors and their patients throughout the United States, said John Goetz, Bio-Rad vice president and group manager of clinical diagnostics.


Related Links:
Sysmex America
Bio-Rad Laboratories

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.